Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine for Cannabis Use in Schizophrenia
NCT00498550Phase 4Completed
- Sponsor
- Dartmouth Health
- Start
- Oct 2000
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clozapine in schizophrenia, cannabis use disorder (CUD), sponsored by Dartmouth Health. Started Oct 2000; status: completed.
02
Drugs
clozapine
03
Conditions
schizophreniacannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00498550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498550.